USA - NASDAQ:MURA - IE000LK2BOB4 - Common Stock
ChartMill assigns a Buy % Consensus number of 46% to MURA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-25 | Jones Trading | Downgrade | Buy -> Hold |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-27 | Jones Trading | Initiate | Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-17 | HC Wainwright & Co. | Initiate | Buy |
| 2024-10-04 | Raymond James | Initiate | Strong Buy |
| 2024-06-28 | Rodman & Renshaw | Initiate | Buy |
| 2024-04-04 | Morgan Stanley | Initiate | Overweight |
7 analysts have analysed MURA and the average price target is 6.12 USD. This implies a price increase of 192.82% is expected in the next year compared to the current price of 2.09.
The consensus rating for MURAL ONCOLOGY PLC (MURA) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering MURAL ONCOLOGY PLC (MURA) is 7.